Display options
Cite
Morris JJ. Silent myocardial ischemia: pathophysiology and clinical recognition. Pharmacotherapy. 1987;7(5):56S-61Sdoi: 10.1002/j.1875-9114.1987.tb04051.x.
Morris, J. J. (1987). Silent myocardial ischemia: pathophysiology and clinical recognition. Pharmacotherapy, 7(5), 56S-61S. https://doi.org/10.1002/j.1875-9114.1987.tb04051.x
Morris, J J. "Silent myocardial ischemia: pathophysiology and clinical recognition." Pharmacotherapy vol. 7,5 (1987): 56S-61S. doi: https://doi.org/10.1002/j.1875-9114.1987.tb04051.x
Morris JJ. Silent myocardial ischemia: pathophysiology and clinical recognition. Pharmacotherapy. 1987;7(5):56S-61S. doi: 10.1002/j.1875-9114.1987.tb04051.x. PMID: 3324059.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley

Pharmacotherapy. 1987;7(5):56S-61S. doi: 10.1002/j.1875-9114.1987.tb04051.x.

Silent myocardial ischemia: pathophysiology and clinical recognition.

Pharmacotherapy

J J Morris

Affiliations

  1. Duke University Medical Center, Durham, NC 27710.

PMID: 3324059 DOI: 10.1002/j.1875-9114.1987.tb04051.x

Abstract

Silent myocardial ischemia is reported to account for approximately one-fifth of all myocardial infarctions and to be very common in patients with a history of angina pectoris. It may also play an important role in sudden cardiac death. Detection of silent ischemia is best accomplished by treadmill testing, electrocardiogram, or Holter monitoring. When detected, it should be treated vigorously in high-risk patients and all postinfarction patients. Recommendations regarding to the ideal therapy still await the results of controlled clinical testing, although preliminary reports indicate that topical nitrates are effective.

Similar articles

MeSH terms

Publication Types

LinkOut - more resources